Correlation Between Biotechnology Portfolio and Computers Portfolio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Portfolio and Computers Portfolio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Portfolio and Computers Portfolio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Portfolio Biotechnology and Computers Portfolio Puters, you can compare the effects of market volatilities on Biotechnology Portfolio and Computers Portfolio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Portfolio with a short position of Computers Portfolio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Portfolio and Computers Portfolio.

Diversification Opportunities for Biotechnology Portfolio and Computers Portfolio

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Biotechnology and Computers is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Portfolio Biotec and Computers Portfolio Puters in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Computers Portfolio and Biotechnology Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Portfolio Biotechnology are associated (or correlated) with Computers Portfolio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Computers Portfolio has no effect on the direction of Biotechnology Portfolio i.e., Biotechnology Portfolio and Computers Portfolio go up and down completely randomly.

Pair Corralation between Biotechnology Portfolio and Computers Portfolio

Assuming the 90 days horizon Biotechnology Portfolio is expected to generate 2.11 times less return on investment than Computers Portfolio. In addition to that, Biotechnology Portfolio is 1.68 times more volatile than Computers Portfolio Puters. It trades about 0.07 of its total potential returns per unit of risk. Computers Portfolio Puters is currently generating about 0.24 per unit of volatility. If you would invest  9,850  in Computers Portfolio Puters on May 5, 2025 and sell it today you would earn a total of  1,498  from holding Computers Portfolio Puters or generate 15.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Biotechnology Portfolio Biotec  vs.  Computers Portfolio Puters

 Performance 
       Timeline  
Biotechnology Portfolio 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Portfolio Biotechnology are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Biotechnology Portfolio may actually be approaching a critical reversion point that can send shares even higher in September 2025.
Computers Portfolio 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Computers Portfolio Puters are ranked lower than 18 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Computers Portfolio showed solid returns over the last few months and may actually be approaching a breakup point.

Biotechnology Portfolio and Computers Portfolio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Portfolio and Computers Portfolio

The main advantage of trading using opposite Biotechnology Portfolio and Computers Portfolio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Portfolio position performs unexpectedly, Computers Portfolio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Computers Portfolio will offset losses from the drop in Computers Portfolio's long position.
The idea behind Biotechnology Portfolio Biotechnology and Computers Portfolio Puters pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets